FHIR
© HL7.org |
Server Home
|
XIG Home
|
Server Source
|
FHIR
FHIR IG Statistics: FHIR Resources
Version:
All
|
R2
|
R2B
|
R3
|
R4
|
R4B
|
R5
|
R6
Authority:
All
|
hl7
|
ihe
|
national
Realm:
All
|
BNW
|
au
|
be
|
br
|
ca
|
ch
|
cl
|
cr
|
cz
|
de
|
dk
|
ee
|
eu
|
fi
|
fr
|
il
|
in
|
it
|
jp
|
nl
|
no
|
nz
|
pt
|
se
|
sl
|
stt
|
tw
|
uk
|
us
|
uv
|
vn
View:
All
|
Resource Profiles
|
Datatype Profiles
|
Extensions
|
Logical Models
|
CodeSystems
|
ValueSets
|
ConceptMaps
Resources - All Kinds, Realm US, Authority Hl7
16,284 resources
Type:
ActivityDefinition
ActorDefinition
CapabilityStatement
CodeSystem
ConceptMap
ExampleScenario
GraphDefinition
ImplementationGuide
Measure
MessageDefinition
NamingSystem
OperationDefinition
PlanDefinition
Questionnaire
Requirements
SearchParameter
StructureDefinition
StructureMap
TerminologyCapabilities
TestScript
ValueSet
Text:
By Version
R2
: 52
R2B
: 0
R3
: 523
R4
: 15,269
R4B
: 0
R5
: 440
R6
: 0
Start
Prev
Rows 10200 - 10400
Next
Package
Version
Identity
Name/Title
Status
FMM
WG
Date
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.496
Pembrolizumab
active
2024-09
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.497
Dostarlimab
active
2024-09
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.498
Selpercatinib
active
2024-09
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.499
Everolimus
active
2024-09
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.500
Trastuzumab_deruxtecan
active
2024-09
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.501
Test 23
active
2024-09
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.502
All Metastatic sites Endometrial SNOMED
active
2024-09
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.503
All Metastatic sites Endometrial ICD9
active
2024-09
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.504
All Metastatic sites Endometrial ICD10
active
2024-09
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.505
All Metastatic sites Endometrial
active
2024-09
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.506
Create CRC_Cancer_T4a_Stage
active
2024-10
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.507
Create CRC_Cancer_T4b_Stage
active
2024-10
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.508
High Emetogenic Risk Chemotherapy
active
2025-04
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.510
InactiveFollowup
active
2025-05
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.53
MMR Gene Testing
active
2023-11
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.54
MSI High
active
2023-11
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.55
MSI High
active
2024-01
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.6
Orserdu
active
2023-08
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.61
Stage IIB or lower and limited
active
2023-11
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.62
Stage III or higher
active
2023-11
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.63
Stage III or higher
active
2023-11
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.64
Stage III or higher
active
2023-11
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.65
Staging Unknown
active
2023-11
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.66
Staging Unknown
active
2023-11
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.67
Staging Unknown
active
2023-11
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.68
Jemperli
active
2023-11
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.69
Uterine Sarcoma
active
2023-11
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.7
Her2 Test For Orserdu
active
2023-09
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.70
Tumor Histology
active
2023-11
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.71
Platinum based therapy
active
2023-11
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.72
Prior Therapies for Tucatinib
active
2023-12
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.73
Tucatinib
active
2023-12
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.74
Colorectal Cancer ICD10
active
2023-12
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.75
Colorectal Cancer ICD9
active
2023-12
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.76
Colorectal Cancer ICD9 and ICD10
active
2023-12
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.78
Advanced or Unresectable Colorectal Cancer Staging
active
2023-12
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.79
0 to IIIB Colorectal Cancer Staging
active
2023-12
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.80
Colorectal Cancer M1 Stage
active
2023-12
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.81
RAS Genes
active
2023-12
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.82
RAS Gene Interpretation Negative LOINC
active
2023-12
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.83
RAS Gene Interpretation Negative SNOMED
active
2023-12
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.84
RAS Gene Interpretation Negative NCM
active
2023-12
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.85
RAS Gene Negative
active
2023-12
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.86
RAS Gene Interpretation Positive SNOMED
active
2023-12
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.87
RAS Gene Interpretation Positive LOINC
active
2023-12
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.88
RAS Gene Positive
active
2023-12
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.89
Her2 Testing
active
2023-12
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.90
Patient Reason
active
2023-12
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.91
MSI High NCI
active
2024-01
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.92
MSI Low SNOMED
active
2024-01
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.93
MSI Low LOINC
active
2024-01
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.94
MSI Low NCI
active
2024-01
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.95
MSI Low
active
2024-01
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.96
MMR Deficient NCI
active
2024-01
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.97
MMR Proficient SNOMED
active
2024-01
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.98
MMR Proficient LOINC
active
2024-01
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1260.99
MMR Proficient NCI
active
2024-01
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1262.3
ICD9 Codes for HIV Diagnosis
active
2023-10
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1264.1
Inpatient Pneumonia Diagnosis
active
2023-12
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1264.11
Chest Imaging for Pneumonia, HCPCS
active
2023-11
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1264.12
Chest Imaging for Pneumonia Grouping Definition
active
2024-09
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1264.18
ICD9 Abnormal Finding on Chest Imaging
active
2023-12
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1264.19
ICD10 Abnormal Finding on Chest Imaging
active
2023-12
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1264.2
ICD9 Pneumonia Definition
active
2023-11
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1264.20
SNOMEDCT Abnormal Finding on Chest Imaging
active
2023-12
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1264.21
Abnormal Finding on Chest Imaging
active
2023-12
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1264.22
SNOMEDCT Pneumonia Definition
active
2023-12
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1264.23
CAP Concurrent Infections
active
2024-09
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1264.24
CAP Pneumonia Diagnostic
active
2024-12
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1264.25
Antibiotic Usage for CAP Diagnosis
active
2024-10
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1264.27
Legionella Presence by Urine Antigen or DNA
active
2024-09
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1264.29
Broad Spectrum Antibiotics for MDRO
active
2024-10
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1264.3
ICD10 Pneumonia Definition
active
2023-11
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1264.32
CPT Transplants, Stem Cell and Solid
active
2024-12
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1264.33
HCPCS Transplant, Stem Cell and Solid
active
2024-12
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1264.34
ICD10CM Transplant, Stem Cell and Solid
active
2024-12
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1264.35
ICD10PCS Transplant, Stem Cell and Solid
active
2024-12
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1264.37
SNOMEDCT Transplant, Stem Cell and Solid
active
2024-12
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1264.38
Transplant, Stem Cell and Solid
active
2024-12
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1264.39
Antibiotic Usage for CAP Duration
active
2024-12
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1264.40
CAP Sepsis Diagnostic
active
2024-12
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1264.41
CAP Respiratory Failure Diagnostic
active
2024-12
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1264.42
MRSA Organism or Substance in Lab Results
active
2024-12
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1264.8
Systemic Antimicrobials
active
2023-11
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1264.9
Chest Imaging for Pneumonia, CPT
active
2023-11
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1267.1
Problem Type
active
2025-04
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1267.10
Information Source for Medication Adherence HSLOC
active
2024-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1267.11
Information Source for Medication Adherence
active
2024-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1267.14
Unknown and Asked but Unknown (DAR)
active
2024-10
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1267.15
Yes or No SCT
active
2024-10
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1267.16
Answer Set with Yes No and Unknowns
active
2024-10
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1267.17
Common LOINC Lab Codes
active
2024-10
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1267.18
Radiology Procedures (LOINC)
active
2024-10
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1267.21
Universal Common LOINC Lab Orders
active
2024-10
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1267.22
Route of Administration of Therapeutic Agents
active
2024-10
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1267.23
Encounter Type
active
2025-05
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1267.27
Social History Type (LOINC)
active
2025-05
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1267.28
Social History Type
active
2025-04
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1267.3
Smoking status comprehensive
active
2024-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1267.4
Smoking Status Type LOINC
active
2024-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1267.5
Smoking Status Pack Years SCT
active
2024-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1267.6
Smoking Status Type
active
2024-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1267.7
Information Source for Medication Adherence HL7 Role Code
active
2024-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1267.8
Information Source for Medication Adherence ParticpationFunction
active
2024-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1267.9
Information Source for Medication Adherence SCT
active
2024-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1272.1
Malnutrition
active
2024-10
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1272.10
Fracture
active
2025-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1272.11
Transplant Diagnoses
active
2025-04
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1272.13
Transplant Diagnoses ICD10CM
active
2025-04
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1272.14
Transplant Diagnoses SNOMED CT
active
2025-04
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1272.15
Respiratory Procedures
active
2025-04
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1272.3
Diabetes
active
2025-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1272.4
Diabetes
active
2025-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1272.5
Diabetes
active
2025-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1272.6
Immobility
active
2025-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1272.7
Smoking status
active
2025-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1272.8
Obesity
active
2025-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1272.9
Hormone Therapy
active
2025-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1282.1
Drug Intervention Not Indicated/Contraindicated
active
2024-11
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1282.10
Endotracheal Intubation
active
2025-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1282.2
Procedure Not Indicated/Contraindicated
active
2024-11
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1282.9
Mechanical Circulatory Assist Device
active
2025-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1289.1
RXNormSBD0305
active
2025-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1289.2
RXNormSCD0305
active
2025-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1290.4
Sequential Organ Failure Assessment SOFA
active
2025-04
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.1.11.10612
Unknown Null
active
2019-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.1.11.19601
x_ServiceEventPerformer
active
2024-06
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.1.11.20549
Criticality Observation
active
2024-06
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.10.20.15.2.5.1
Initial Case Report Trigger Code Result Status
active
2024-08
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.10.20.15.2.5.12
Therapeutic Response to Medication
active
2024-08
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.10.20.5.1.5.9.2
Codes for MDRO and CDI Summary Data LTCF
active
2020-08
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.10.20.5.1.5.9.3
NHSNPrimaryResidentServiceType
active
2020-06
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.10.20.5.1.5.9.4
Codes for Denominators for Long Term Care Locations LTCF
active
2023-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.10.20.5.1.5.9.5
Codes for Prevention Process Measures LTCF
active
2023-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.10.20.5.1.9.1
NHSNReportNoEventsMDROLTCF
active
2020-08
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.10.20.5.9.10
Codes for Healthcare Personnel Influenza Vaccination (HP FLU) Summary Data
active
2019-08
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.10.20.5.9.11
Codes for Hemovigilance (HV) Summary Data
active
2020-08
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.10.20.5.9.12
Codes for Intensive Care Unit (ICU) Summary Data
active
2020-08
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.10.20.5.9.13
Codes for Neonatal Intensive Care Unit (NICU) Summary Data
active
2020-08
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.10.20.5.9.15
Codes for Prevention Process and Outcome Measures (POM) Summary Data
active
2020-08
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.10.20.5.9.16
Codes for Specialty Care Area (SCA) Summary Data
active
2020-08
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.10.20.5.9.17
Codes for Vascular Access Type (Dialysis) Summary Data
active
2020-08
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.10.20.5.9.18
NHSNReportNoEventsICU
active
2020-08
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.10.20.5.9.19
NHSNReportNoEventsNICU
active
2020-08
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.10.20.5.9.20
NHSNReportNoEventsSCA
active
2020-08
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.10.20.5.9.21
NHSNReportNoEventsMDRO
active
2020-08
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.10.20.5.9.22
NHSNReportNoEventsDialysis
active
2020-08
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.10.20.5.9.24
NHSNVascularSpecimenCollectionSite
active
2022-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.10.20.5.9.29
NHSNSSIDetectionMethod
active
2020-08
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.10.20.5.9.3
NHSNLastLocationEncounterTypeCode
active
2020-06
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.10.20.5.9.30
NHSNLOS/MENDischargeDisposition
active
2022-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.10.20.5.9.31
NHSNSSIDetectionMethodType
active
2020-08
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.10.20.5.9.32
Codes for Outpatient Procedure Component Same Day Outcome Measures Summary Data
active
2020-08
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.10.20.5.9.33
NHSNReportNoEventsOPCSameDayOutcomeMeasures
active
2020-08
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.10.20.5.9.34
NHSNOPCProcedureCategoryCode
active
2020-08
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.10.20.5.9.35
NHSNReportNoEventsAR
active
2020-08
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.10.20.5.9.4
NHSNDrugSusceptibilityTestMethod
active
2020-04
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.10.20.5.9.40
NHSN COVID19 Case Classification
active
2021-04
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.10.20.5.9.5
NHSN Pathogen Reduced Apheresis Platelet Usage
active
2020-08
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.10.20.5.9.50
NHSNGenotypicTestInterpretation
active
2024-08
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.10.20.5.9.6
HealthcarePersonnelType
active
2020-08
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.10.20.5.9.7
NHSNInfluenzaVaccinationSetting
active
2022-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.10.20.5.9.8
Codes for Antimicrobial Resistance Option (ARO) Summary Data
active
2020-11
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.10.20.5.9.9
Codes for Antimicrobial Usage, Pharmacy (AUP) Summary Data
active
2020-08
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.11.20.12.1
Personal And Legal Relationship Role Type
active
2024-06
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.11.20.9.21
AgePQ_UCUM
active
2024-06
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.11.20.9.32
DIRDocumentTypeCodes
active
2024-06
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.11.20.9.47
ADL Result Type
active
2024-06
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.11.20.9.49
Residence and Accommodation Type
active
2024-06
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.11.20.9.50
Sensory Status Problem Type
active
2024-06
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.11.20.9.51
Healthcare Agent Qualifier
active
2024-06
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.11.20.9.52
Encounter SCT
active
2024-10
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.11.20.9.56
Referral Types
active
2024-06
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.11.20.9.62
Related Document (append/replace)
active
2024-06
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.11.20.9.66
Patient Referral Act moodCode
active
2024-06
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.11.20.9.68
Note Types
active
2024-06
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.11.20.9.69.4
Advance Healthcare Directive Categories LOINC
active
2025-04
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.13.1
NHSNEncounterTypeCode
active
2019-08
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.13.10
NHSNASAClassCode
active
2019-08
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.13.11
NHSNSpinalFusionLevelCode
active
2020-08
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.13.12
NHSNOccasionOfDetectionCode
active
2020-08
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.13.13
NHSNDrugSusceptibilityFindingCode
active
2020-04
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.13.15
NHSNDrugSusceptibilityTestsCode
active
2025-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.13.16
NHSNPathogenCode
active
2023-11
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.13.17
NHSNProcedureCategoryCode
active
2020-08
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.13.19
NHSNHealthcareServiceLocationCode
active
2019-08
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.13.2
NHSNSpinalFusionApproachCode
active
2022-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.13.20
NHSNInfectionTypeCode
active
2022-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.13.3
NHSNHipReplacementCode
active
2020-08
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.13.4
NHSNKneeReplacementCode
active
2020-08
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.13.6
NHSNInfectionRiskFactorsCode
active
2020-08
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.13.7
NHSNBloodStreamInfectionEvidenceTypeCode
active
2020-08
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.13.9
NHSNWoundClassCode
active
2020-07
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.17.4077.2.1017
Closed Head and Facial Trauma
active
2020-09
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.17.4077.2.1018
Closed Head and Facial Trauma
active
2025-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.117.1.7.1.134
Oral Factor Xa Inhibitor for VTE Prophylaxis or VTE Treatment
active
2022-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.117.1.7.1.136
Perforation of Uterus
active
2024-04
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.117.1.7.1.137
Uterine Window
active
2021-06
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.117.1.7.1.138
Uterine Rupture
active
2024-04
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.117.1.7.1.200
Anticoagulant Therapy
active
2025-02